References

Arankalle VA, Chobe LP. Retrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis E. Vox Sang. 2000; 79:72-74
Deuffic-Burban S, Delarocque-Astagneau E, Abiteboul D Blood-borne viruses in health care workers: prevention and management. J Clin Virol. 2011; 52:4-10
Pruss-Ustun A, Rapiti E, Hutin Y. Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am J Ind Med. 2005; 48:482-490
World Health Organization. Global Hepatitis Report. 2017. http://www.who.int/publications/i/item/global-hepatitis-report-2017 (accessed December 2021)
Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019; 70:151-171
Scottish Public Health Observatory. Chronic liver disease: deaths. 2019. https://www.scotpho.org.uk/health-wellbeing-and-disease/chronic-liver-disease/data/mortality (accessed December 2021)
British Liver Trust. The alarming impact of liver disease in the UK: facts and statistics. 2019. https://britishlivertrust.org.uk/about-us/media-centre/statistics/ (accessed December 2021)
Gerlich WH. Medical virology of hepatitis B: how it began and where we are now. Virol J. 2013; 10
Seeger C, Mason WS. Molecular biology of hepatitis B virus infection. Virology. 2015; 479-480:672-686
World Health Organization. WHO Factsheet Hepatitis B. 2020. http://www.who.int/news-room/fact-sheets/detail/hepatitis-b (accessed December 2021)
Health and Safety Executive. Hepatitis B virus (HBV). 2015. http://www.hse.gov.uk/biosafety/blood-borne-viruses/hepatitis-b.htm (accessed December 2021)
Werner BG, Grady GF. Accidental hepatitis-B-surface-antigen-positive inoculations. Use of e antigen to estimate infectivity. Ann Intern Med. 1982; 97:367-369
Komatsu H, Inui A, Sogo T Tears from children with chronic hepatitis B virus (HBV) infection are infectious vehicles of HBV transmission: experimental transmission of HBV by tears, using mice with chimeric human livers. J Infect Dis. 2012; 206:478-485
Petersen NJ, Bond WW, Favero MS. Air sampling for hepatitis B surface antigen in a dental operatory. J Am Dent Assoc. 1979; 99:465-467
Kew MC. Possible transmission of serum (Australia-antigen-positive) hepatitis via the conjunctiva. Infect Immun. 1973; 7:823-824
Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008; 48:335-352
NHS. Hepatitis B vaccine overview. 2020. https://www.nhs.uk/conditions/vaccinations/hepatitis-b-vaccine/ (accessed December 2021)
Scotland Public Health Observatory. Childhood Immunisation Statistics Scotland. 2020. http://www.scotpho.org.uk/health-wellbeing-and-disease/immunisations/data/children/ (accessed December 2021)
NHS Digital. Childhood vaccination coverage statistics. 2021. https://digital.nhs.uk/data-and-information/publications/statistical/nhs-immunisation-statistics (accessed December 2021)
Puro V, De Carli G, Cicalini S European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus. Euro Surveill. 2005; 10:260-264
Zuckerman JN. Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol. 2006; 78:169-177
Struve J, Aronsson B, Frenning B Seroconversion after additional vaccine doses to non-responders to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine. Scand J Infect Dis. 1994; 26:468-470
Kubba AK, Taylor P, Graneek B, Strobel S. Non-responders to hepatitis B vaccination: a review. Commun Dis Public Health. 2003; 6:106-112
Pfaender S, von Hahn T, Steinmann J prevention strategies for blood-borne viruses-in the era of vaccines, direct acting antivirals and antiretroviral therapy. Rev Med Virol. 2016; 26:330-339
Huang DQ, Lim SG. Hepatitis B: who to treat? A critical review of international guidelines. Liver Int. 2020; 40:5-14
UK Health Security Agency. Integrated guidance on health clearance of healthcare workers and the management of healthcare workers infected with bloodborne viruses (hepatitis B, hepatitis C and HIV). https://tinyurl.com/2p8rsncb (accessed December 2021)
Lampertico P, Agarwal K, Berg T EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017; 67:370-398
Westin J, Aleman S, Castedal M Management of hepatitis B virus infection, updated Swedish guidelines. Infect Dis (Lond). 2020; 52:1-22
Choo QL, Kuo G, Weiner AJ Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989; 244:359-362
World Health Organization. WHO Factsheet Hepatitis C. 2020. https://www.who.int/news-room/fact-sheets/detail/hepatitis-c (accessed December 2021)
European Centre for Disease and Prevention Control. Epidemiological assessment of hepatitis B and C among migrants in the EU/EEA 2016. http://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/epidemiological-assessment-hepatitis-B-and-C-among-migrants-EU-EEA.pdf (accessed December 2021)
Smith BD, Beckett GA, Yartel A Previous exposure to HCV among persons born during 1945-1965: prevalence and predictors, United States, 1999–2008. Am J Public Health. 2014; 104:474-481
Nainan OV, Alter MJ, Kruszon-Moran D Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States. Gastroenterology. 2006; 131:478-484
Kemp L, Clare KE, Brennan PN, Dillon JF. New horizons in hepatitis B and C in the older adult. Age Ageing. 2019; 48:32-37
Pradat P, Voirin N, Tillmann HL Progression to cirrhosis in hepatitis C patients: an age-dependent process. Liver Int. 2007; 27:335-339
Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 1995; 332:1463-1466
Kallwitz ER, Layden-Almer J, Dhamija M Ethnicity and body mass index are associated with hepatitis C presentation and progression. Clin Gastroenterol Hepatol. 2010; 8:72-78
Poynard T, Ratziu V, Charlotte F Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol. 2001; 34:730-739
CDC. Hepatitis C questions and answers for health professionals. 2020. https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm (accessed December 2021)
EASL recommendations on treatment of hepatitis C: final update of the series. J Hepatol. 2020; 73:1170-1218 https://doi.org/10.1016/j.jhep.2020.08.018
Åberg F, Helenius-Hietala J, Meurman J, Isoniemi H. Association between dental infections and the clinical course of chronic liver disease. Hepatology Res. 2014; 44:349-353
Guggenheimer J, Eghtesad B, Close JM Dental health status of liver transplant candidates. Liver Transpl. 2007; 13:280-286
Cruz-Pamplona M, Margaix-Munoz M, Sarrion-Perez MG. Dental considerations in patients with liver disease. J Clin Exp Dent. 2011; 3:e127-e134
Dwyer JP, Jayasekera C, Nicoll A. Analgesia for the cirrhotic patient: a literature review and recommendations. J Gastroenterol Hepatol. 2014; 29:1356-1360
Chandok N, Watt KD. Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin Proc. 2010; 85:451-458
Lewis JH, Stine JG. Review article: prescribing medications in patients with cirrhosis – a practical guide. Aliment Pharmacol Ther. 2013; 37:1132-1156
Andrade RJ, Tulkens PM. Hepatic safety of antibiotics used in primary care. J Antimicrob Chemother. 2011; 66:1431-1446
Helenius-Hietala J, Meurman JH, Hockerstedt K Effect of the aetiology and severity of liver disease on oral health and dental treatment prior to transplantation. Transpl Int. 2012; 25:158-165
Shah NL, Caldwell SH. Assessing the risk of bleeding and clotting in cirrhosis. Clin Liver Dis (Hoboken). 2016; 7:26-28
Flores B, Trivedi HD, Robson SC, Bonder A. Hemostasis, bleeding and thrombosis in liver disease. J Transl Sci. 2017;
Tripodi A, Primignani M, Chantarangkul V Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology. 2006; 44:440-445
Hong CH, Scobey MW, Napenas JJ Dental postoperative bleeding complications in patients with suspected and documented liver disease. Oral Dis. 2012; 18:661-666
Scottish Dental Clinical Effectiveness Programme (SDCEP). Management of dental patients taking anticoagulants or antiplatelet drugs - dental clinical guidance. 2015. https://www.sdcep.org.uk/wp-content/uploads/2015/09/SDCEP-Anticoagulants-Guidance.pdf (accessed 26 Aug 2020)
CDA Foundation, Polaris Observatory. Global distribution of hepatitis B and hepatitis C. 2021. https://cdafound.org/polaris-countries-distribution/ (accessed December 2021)

Hepatitis B, Hepatitis C and Liver Disease: A Review for the Dental Practitioner

From Volume 49, Issue 1, January 2022 | Pages 26-30

Authors

Iain Macpherson

MBChB, MRCP(UK)

Clinical Research Fellow, Division of Clinical and Molecular Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee

Articles by Iain Macpherson

Paul N Brennan

MBChB MRCP(UK)

Clinical Research Fellow, Centre for Regenerative Medicine, University of Edinburgh

Articles by Paul N Brennan

John F Dillon

MD, MRCP(UK)

Professor of Gastroenterology and Hepatology, Division of Clinical and Molecular Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee

Articles by John F Dillon

Email John F Dillon

Abstract

The prevalence of chronic liver disease continues to rise, and important causes include viral infections, such as hepatitis B and hepatitis C. Both of these viruses can be contracted by healthcare workers through an inoculation injury and can lead to liver cirrhosis and cancer. In addition, chronic liver disease can result in disorders of liver function, including coagulopathy and abnormal metabolism of drugs widely used in dentistry. This article reviews current prevalence, transmission rates and treatment of hepatitis B and hepatitis C, as well as particular considerations for dental patients with liver disease.

CPD/Clinical Relevance: Viral hepatitis remains a risk to all healthcare workers, and patients with liver disease provide various challenges when providing dental treatment.

Article

Blood borne viruses (BBVs) are transmitted through the transfer of blood or other virus-containing bodily fluids between individuals. Hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) account for the majority of such infections, while there is evidence that hepatitis E virus (HEV), usually transmitted through the faecal–oral route, can also be transmitted through blood to blood transfer.1,2

Globally, healthcare workers (HCWs), including dentists, are at risk of contracting such infections. Routes of transmission include inoculation injury, and blood or saliva entry through a wound. In 2000, it was estimated that HCWs contracted 66,000 HBV and 16,000 HCV infections through percutaneous injuries (PIs).3

HBV, HCV and HEV often result in acute, self-limiting illnesses, but can lead to chronic infection, resulting in chronic inflammation of the liver (hepatitis). Chronic viral hepatitis can cause liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC), and in some countries is the leading cause of liver transplantation.4

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available